|
| Dasatinib DiMeric IMpurity Basic information |
Product Name: | Dasatinib DiMeric IMpurity | Synonyms: | Dasatinib DiMeric IMpurity;Dasatinib Impurity 8 (Dasatinib Dimeric Impurity);2,2'-[1,4-Piperazinediylbis[(2-methyl-6,4-pyrimidinediyl)imino]]bis[N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide;Dasatinib Dimer Impurity;Dasatinib impurity 6/Dasatinib Dimeric Impurity/2,2'-((piperazine-1,4-diylbis(2-methylpyrimidine-6,4-diyl))bis(azanediyl))bis(N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide);dasatinib Dimer IMP;N-(2-chloro-6-methylphenyl);5-Thiazolecarboxamide, 2,2'-[1,4-piperazinediylbis[(2-methyl-6,4-pyrimidinediyl)imino]]bis[N-(2-chloro-6-methylphenyl)- (9CI) | CAS: | 910297-61-9 | MF: | C36H34Cl2N12O2S2 | MW: | 801.77 | EINECS: | | Product Categories: | Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors | Mol File: | 910297-61-9.mol | |
| Dasatinib DiMeric IMpurity Chemical Properties |
density | 1.501±0.06 g/cm3(Predicted) | storage temp. | Refrigerator | solubility | DMSO (Very Slightly) | form | Solid | pka | 10?+-.0.70(Predicted) | color | Off-White to Dark Beige |
| Dasatinib DiMeric IMpurity Usage And Synthesis |
Uses | Dasatinib Dimeric Impurity, is an impurity of Dasatinib (D193600), which is a new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. It is also an Antineoplastic. It is a COVID19-related research product. |
| Dasatinib DiMeric IMpurity Preparation Products And Raw materials |
|